Patents by Inventor Vernon D. Ortenzi
Vernon D. Ortenzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10157263Abstract: Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) by an injection data management module (660) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), contrast media data for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780) on the injection data management module (660). Patient renal function data may be used to control the dispensing of contrast media from a contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.Type: GrantFiled: May 7, 2013Date of Patent: December 18, 2018Assignee: LIEBEL-FLARSHEIM COMPANY LLCInventors: Vernon D. Ortenzi, John Edward Powers, Robert J. Ziemba, Rhonda J. Soest, Pamela L. Pollard
-
Patent number: 10117988Abstract: Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), data on contrast media dispensed from a contrast media storage/dispensing unit (500) for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780). Patient renal function data may be used to control the dispensing of contrast media from the contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.Type: GrantFiled: May 9, 2012Date of Patent: November 6, 2018Assignee: LIEBEL-FLARSHEIM COMPANY LLCInventors: Vernon D. Ortenzi, John Edward Powers, Robert J. Ziemba, Rhonda J. Soest, Pamela L. Pollard
-
Patent number: 9579252Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: GrantFiled: May 19, 2015Date of Patent: February 28, 2017Assignee: Mallinckrodt LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 9414989Abstract: Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).Type: GrantFiled: September 16, 2014Date of Patent: August 16, 2016Assignee: MALLINCKRODT LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Publication number: 20150250677Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: ApplicationFiled: May 19, 2015Publication date: September 10, 2015Inventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 9120607Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: GrantFiled: November 27, 2013Date of Patent: September 1, 2015Assignee: MALLINCKRODT LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 9046403Abstract: Systems and methods for managing use of a pharmaceutical product are provided. The systems and methods utilize an external cover and a container, along with a first material and a pharmaceutical product that are each contained within an internal space that exists when the external cover is in a closed position relative to the container. Release of the first material may bond the external cover to the container, may result in the first material coming into contact with the pharmaceutical product, or both.Type: GrantFiled: January 27, 2011Date of Patent: June 2, 2015Assignee: MALLINCKRODT LLCInventors: Vernon D. Ortenzi, Robert J. Ziemba, Simon Alexander Karger, Brandon Craft, Pari Datta, Andrew Robert Mawby, Jeremy Bickerstaffe
-
Publication number: 20150127376Abstract: Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) by an injection data management module (660) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), contrast media data for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780) on the injection data management module (660). Patient renal function data may be used to control the dispensing of contrast media from a contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.Type: ApplicationFiled: May 7, 2013Publication date: May 7, 2015Applicant: Mallinckrodt LLCInventors: Vernon D. Ortenzi, John Edward Powers, Robert J. Ziemba, Rhonda J. Soest, Pamela J. Pollard
-
Patent number: 9016516Abstract: Pharmaceutical product dispensers (e.g., in the shape of a common ink pen) are operable to indicate information regarding a dosing schedule of a pharmaceutical product dispensable from the dispenser. Embodiments of the dispensers may include a plurality of dosing segments, each corresponding to a different dose of the pharmaceutical product. Actuation of an actuator may result in interaction between the actuator and the pharmaceutical product storage area such that a dose of pharmaceutical product contained in the pharmaceutical product storage area is dispensed, along with a corresponding advancement of the plurality of dosing segments. The dispenser may also include one or more locks to prevent unauthorized access to the pharmaceutical product (e.g., by a child or the like). Furthermore, the pharmaceutical product dispenser may include a disabling mechanism to permanently disable actuation of the actuator of the dispenser.Type: GrantFiled: May 9, 2011Date of Patent: April 28, 2015Assignee: Mallinckrodt LLCInventors: Vernon D. Ortenzi, Robert J. Ziemba, Frank M. Lewis, Geoffrey S. Strobl
-
Patent number: 8991606Abstract: A pharmaceutical product supply in the form of a container (e.g., secondary packaging) and a pharmaceutical product receiver (e.g., primary packaging) is disclosed. The pharmaceutical product receiver may include a plurality of pockets or receptacles, and may be disposed within the container. Pharmaceutical product may be enclosed within one or more of these receptacles. The pharmaceutical product receiver may be locked to at least some degree within the container to facilitate disposal of the pharmaceutical product supply, for instance at a time when some of the pharmaceutical product may have been removed from the pharmaceutical product receiver but prior to utilizing all of the pharmaceutical product originally provided with the pharmaceutical product receiver.Type: GrantFiled: August 23, 2011Date of Patent: March 31, 2015Assignee: Mallinckrodt LLCInventors: Vernon D. Ortenzi, Robert J. Ziemba
-
Patent number: 8925727Abstract: A transdermal patch container (10) that includes a container body (16), a first compartment (24), and a second compartment (28) is disclosed. One or more first transdermal patches (34) may be stored in the first compartment (24). One or more second transdermal patches (36) may be stored in the second compartment (28). The first transdermal patches (34) differ from the second transdermal patches (36) in at least one respect. A number of features may be incorporated to reduce the potential of being able to withdraw second transdermal patches (36) out of the second compartment (28). For instance, second transdermal patches (36) may be required to be directed through a slot (44) to enter a second compartment (28i). A flap (66) may be positioned below such a slot (58) within a second storage compartment (28ii). A plurality of vertically spaced or staggered flaps (96) may be positioned within a second storage compartment (28iv).Type: GrantFiled: January 27, 2011Date of Patent: January 6, 2015Assignee: Mallinckrodt LLCInventors: Vernon D. Ortenzi, Robert J. Ziemba, Paul Fearis, Brandon Craft
-
Publication number: 20150001102Abstract: Various embodiments of pharmaceutical product containers are disclosed. Each pharmaceutical product container includes a cap, a container body, and a locking mechanism. The locking mechanism is disposable from a locked state to an unlocked state at least when the cap is in a closed position relative to the container body (e.g., to define an enclosed space for pharmaceutical product). Once in the locked state and with the cap being in a closed position, the locking mechanism is unable to return to its unlocked state. Pharmaceutical product enclosed within the container with the locking mechanism being in its locked state may then be disposed of in any appropriate manner (e.g., discarded in the trash).Type: ApplicationFiled: September 16, 2014Publication date: January 1, 2015Applicant: MALLINCKRODT LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 8910456Abstract: A container (100) for storing transdermal patches is disclosed. The container (100) includes a child-resistant mechanism (112) to reduce the likelihood of access to the transdermal patches (TP) by children. The child-resistant mechanism (112) may include first and second access components (116, 120) that may be disposed in a non-opposing manner and that may be in any appropriate form (e.g., buttons). Activation or engagement of the first and second access components (116, 120) in a particular manner allows the container (100) to assume an open configuration to access and/or load patches. In one arrangement, the first and second access components (116, 120) may be simultaneously engaged (e.g., depressed) to open the container (100). In another arrangement, the first and second access components (116, 120) may be engaged in series in a particular sequence to open the container (100).Type: GrantFiled: January 27, 2011Date of Patent: December 16, 2014Assignee: MallinckrodtInventors: Vernon D. Ortenzi, Robert J. Ziemba, Brandon Craft
-
Publication number: 20140331610Abstract: A pharmaceutical product supply including primary packaging (e.g., a blister card) having a plurality of receptacles and pharmaceutical product (e.g., one or more pills, capsules, etc.) enclosed within at least one of the receptacles. Heating the pharmaceutical product supply to at least an activation temperature of a heat-activated encapsulation material associated with the supply may encapsulate the pharmaceutical product to reduce the likelihood that the pharmaceutical product can thereafter be administered, and thereby facilitates disposal of the pharmaceutical product. In one embodiment, a tray of a primary packaging is constructed of the heat-activated encapsulation material. In another embodiment, primary packaging may be disposed within a cavity of secondary packaging (e.g., carton), and the heat-activated encapsulation material may be in the form of a layer that is also located within the cavity.Type: ApplicationFiled: July 21, 2014Publication date: November 13, 2014Inventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 8842501Abstract: Systems and methods for tracking dosage periods are disclosed. The systems and methods may include setting a timer (140) to a predetermined value corresponding to a dosage period in response to the engagement of a cover (110) to a container (120). An indication may be provided that corresponds to a remaining period in the dosage period set by the engagement of the cover (110) and container (120). The indication may also indicate a remaining time period in the dosage period.Type: GrantFiled: January 27, 2011Date of Patent: September 23, 2014Assignee: Mallinckrodt LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Publication number: 20140083900Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: ApplicationFiled: November 27, 2013Publication date: March 27, 2014Applicant: Mallinckrodt LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Publication number: 20140073919Abstract: Contrast administration data that relates to operation of a contrast media injector system (602) may be converted from at least one format (e.g., a CAN-compliant format) to at least one other format (e.g., an HL-7-compliant format) for use by a medical system (600). Data on contrast media prescribed for an imaging operation using an imaging system (690), data on contrast media dispensed from a contrast media storage/dispensing unit (500) for use in this imaging operation, and data on contrast media actually administered/injected by a contrast media injector system (602) for this imaging operation may be stored in a data structure (780). Patient renal function data may be used to control the dispensing of contrast media from the contrast media/storage/dispensing unit (500), to control the operation of the contrast media injector system (602), or both, and may be stored in the data structure (780) as well.Type: ApplicationFiled: May 9, 2012Publication date: March 13, 2014Inventors: Vernon D. Ortenzi, John Edward Powers, Robert J. Ziemba, Rhonda J. Soest, Pamela L. Pollard
-
Patent number: 8627957Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: GrantFiled: December 1, 2012Date of Patent: January 14, 2014Assignee: Mallinckrodt LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi
-
Patent number: 8446280Abstract: An apparatus and method of operation is provided for a contrast media injector having a powered drive ram. The drive ram is designed to interface with a plunger of a syringe in order to move the plunger forward and backward relative to a barrel of the syringe. The syringe, having an RF data tag associated therewith, is mounted on to the contrast media injector. Electromagnetic signals are transmitted from an electromagnetic device of the injector in response to mounting the syringe. Data is electromagnetically read from the RF data tag of the syringe using the electromagnetic device of the injector. The transmitting is terminated after the electromagnetically reading. Medical fluid is then dispensed from the syringe. Electromagnetic signals are transmitted from the electromagnetic device in response to initiation of the dispensing. Data is electromagnetically written to the RF data tag of the syringe using the electromagnetic device of the injector.Type: GrantFiled: January 18, 2008Date of Patent: May 21, 2013Assignee: Mallinckrodt LLCInventors: Vernon D. Ortenzi, Chad M. Gibson, Victor Lee Potter
-
Patent number: 8342331Abstract: A pharmaceutical product supply is disclosed in the form of a container, a pharmaceutical product receiver, pharmaceutical product, an adhesive, and at least one release liner. The pharmaceutical product receiver includes a plurality of receptacles for pharmaceutical product. The container is initially disposed in a first configuration where all of the pharmaceutical product receiver receptacles may be accessible. The container is thereafter disposable in a second configuration where no covering for any of the pharmaceutical product receiver receptacles is accessible through any openable access incorporated by the container. One or more release liners may be moved to expose adhesive for disposing and retaining the container in its second configuration. The noted second configuration of the container facilitates disposal of the pharmaceutical product supply (e.g.Type: GrantFiled: May 9, 2011Date of Patent: January 1, 2013Assignee: Mallinckrodt LLCInventors: Robert J. Ziemba, Vernon D. Ortenzi